Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We describe a family cluster of L. major that became infected by traveling to an endemic focus of CL, which did not respond to intralesional meglumine antimonial treatment whilst two were hospitalized due to the progressive disease that responded to 4 weeks of oral ketoconazole. Parasite genotyping of the internal transcribed spacer 1 gene revealed the same infecting parasite strain in all family members and was the same strain in GenBank that caused mucosal L. major in a tourist who visited several North African countries. We hypothesise a reduced host immune response in the two hospitalized patients.

Original publication

DOI

10.1016/j.ijmmb.2022.05.008

Type

Journal article

Journal

Indian J Med Microbiol

Publication Date

07/2022

Volume

40

Pages

451 - 454

Keywords

DNA sequencing, Ketoconazole, Leishmania major, Antiprotozoal Agents, Humans, Leishmania major, Leishmaniasis, Cutaneous, Meglumine, Meglumine Antimoniate, Organometallic Compounds